title: Brucella abortus strain RB51 can be used to express potentially protective antigens of Toxoplasma gondii.
authors.affiliation: Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, 1410 Prices Fork Road, Blacksburg, VA 24061, USA.
authors.forename: Abey B
authors.initials: AB
authors.lastname: Bandara
authors.forename: Mohamad N
authors.initials: MN
authors.lastname: Selem
authors.forename: Carly N
authors.initials: CN
authors.lastname: Jordan
authors.forename: David S
authors.initials: DS
authors.lastname: Lindsay
authors.forename: Gerhardt G
authors.initials: GG
authors.lastname: Shurig
authors.forename: Nammalwar
authors.initials: N
authors.lastname: Sriranganathan
mesh_terms: D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics*; D001428:Bacterial Vaccines / Q000235:genetics*; D002003:Brucella abortus / Q000235:genetics*; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics*; D015800:Protozoan Proteins / Q000235:genetics; D014122:Toxoplasma / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics
chemical_list: D000953:Antigens, Protozoan; D001428:Bacterial Vaccines; C095047:GRA6 protein, Toxoplasma gondii; C106990:Gra2 protein, Toxoplasma gondii; D015800:Protozoan Proteins; D014614:Vaccines, Synthetic; C067547:surface antigen P22, Toxoplasma